Regional emerging special pathogen treatment center emory university and childrens healthcare of atlanta - the purpose of this proposal is for the awardee, emory university in collaboration with…

Active Cooperative Agreement Awarded Last action

Award ID
U3REP220673
Recipient
Awarding agency
Obligated
$12,476,920

Award facts

Completion date 81% complete
Place of performance
California, USA

Award details come from USAspending.gov.

Description

Regional emerging special pathogen treatment center emory university and childrens healthcare of atlanta - the purpose of this proposal is for the awardee, emory university in collaboration with children's healthcare of atlanta-egleston, to support HHS administration for strategic preparedness and response by maintaining an emerging special pathogens treatment center (resptc) for region 4. The biocontainment unit at emory university hospital is supported by all of emory healthcare in partnership with emory university. The expected outcomes of this project are to: - serve as regional leaders in developing, disseminating, and maintaining standards, guidance, and promising practices for high-quality, coordinated special pathogen care and for decision-making during a special pathogen outbreak. - build capacity for the national special pathogen system (nsps) to accelerate special pathogen research, serving as a regional hub to conduct, participate in, and share insights related to special pathogen and clinical trial research. - maintain a trained, diverse, and specialized workforce across their region and the nsps, serve as a regional leader in providing special pathogen trainings, explore innovative and flexible health care workforce solutions, and share resources and promising practices to develop and maintain workforce capabilities to respond to special pathogens surge events. As the first biocontainment unit in the US, the first hospital to care for patients with ebola, one of the leading institutions for the national emerging special pathogens training and education center, and a designated resptc since 2015, emory is well positioned to remain the region IV resptc. In addition to the resptc assets curated since the creation of the serious communicable diseases unit, emory also serves as the southeastern regional disaster health response system.

Transactions

Action Obligated Date
Amendment $0
Amendment $1,615,384
Amendment $2,000,000
Amendment $0
Amendment $1,615,384
Amendment $1,615,384
Amendment $1,615,384
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $1,615,384
Amendment $0
Amendment $0
Amendment $1,200,000
Original award $1,200,000
Show all 18

Subawards

Subrecipient Amount Awarded
Childrens Healthcare Of Atlanta, Inc. Regional Emerging Special Pathogen Treatment Center Emory University & Children's $344,410
Childrens Healthcare Of Atlanta, Inc. Regional Emerging Special Pathogen Treatment Center Emory University and Childrens $344,410
Childrens Healthcare Of Atlanta, Inc. Regional Emerging Special Pathogen Treatment Center Emory University & Children's $234,605
Arthur M. Blank Hospital, Inc. Regional Emerging Special Pathogen Treatment Center Emory University and Childrens $314,379
Scottish Rite Children's Medical Center, Inc. $229,984

Quick answers

Who received award U3REP220673?

U3REP220673 was awarded to Emory University by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 30, 2022.

How much is award U3REP220673 worth?

$12,476,920 has been obligated on U3REP220673.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award